SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Laboratory Corp of America Holdings – ‘10-Q’ for 3/31/16 – ‘R9’

On:  Friday, 5/6/16, at 2:28pm ET   ·   For:  3/31/16   ·   Accession #:  920148-16-193   ·   File #:  1-11353

Previous ‘10-Q’:  ‘10-Q’ on 10/30/15 for 9/30/15   ·   Next:  ‘10-Q’ on 7/29/16 for 6/30/16   ·   Latest:  ‘10-Q’ on 4/30/24 for 3/31/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 5/06/16  Lab Corp of America Holdings      10-Q        3/31/16   70:7.6M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    519K 
 2: EX-12.1     Statement re: Computation of Ratios                 HTML     49K 
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     26K 
 4: EX-31.2     Certification -- §302 - SOA'02                      HTML     26K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     24K 
12: R1          Document and Entity Information Document            HTML     46K 
13: R2          Condensed Consolidated Balance Sheets (Unaudited)   HTML    104K 
14: R3          Condensed Consolidated Balance Sheets (Unaudited)   HTML     28K 
                (Parentheticals)                                                 
15: R4          Condensed Consolidated Statements of Operations     HTML     84K 
                (Unaudited)                                                      
16: R5          Condensed Consolidated Statements of Comprehensive  HTML     61K 
                Earnings (Unaudited)                                             
17: R6          Condensed Consolidated Statements of Changes in     HTML     63K 
                Shareholders' Equity (Unaudited)                                 
18: R7          Condensed Consolidated Statements of Cash Flows     HTML    125K 
                (Unaudited)                                                      
19: R8          Basis of Financial Statement Presentation           HTML     41K 
20: R9          Earnings Per Share                                  HTML     60K 
21: R10         Restructuring and Other Special Charges             HTML     56K 
22: R11         Goodwill and Intangible Assets                      HTML     89K 
23: R12         Debt                                                HTML     75K 
24: R13         Preferred Stock and Common Shareholders' Equity     HTML     59K 
25: R14         Income Taxes                                        HTML     31K 
26: R15         Commitments and Contingencies                       HTML     70K 
27: R16         Pension and Postretirement Plans                    HTML    140K 
28: R17         Fair Value Measurements                             HTML     63K 
29: R18         Derivative Instruments and Hedging Activities       HTML     40K 
30: R19         Supplemental Cash Flow Information                  HTML     52K 
31: R20         Business Acquisitions                               HTML    103K 
32: R21         BUSINESS SEGMENT INFORMATION Business Segment       HTML     54K 
                information (Notes)                                              
33: R22         Earnings Per Share (Tables)                         HTML     60K 
34: R23         RESTRUCTURING AND OTHER SPECIAL CHARGES             HTML     86K 
                Restructuring and Other Special Charges Detail                   
                (Tables)                                                         
35: R24         Goodwill and Intangible Assets (Tables)             HTML     86K 
36: R25         Debt (Tables)                                       HTML     54K 
37: R26         Debt (Short-term borrowings and current portion of  HTML     45K 
                long-term debt) (Table) (Details)                                
38: R27         Debt (Long-term debt) (Table) (Details)             HTML    129K 
39: R28         Preferred Stock and Common Shareholders' Equity     HTML     50K 
                (Tables)                                                         
40: R29         Pension and Postretirement Plans (Tables)           HTML    154K 
41: R30         Fair Value Measurements (Tables)                    HTML     56K 
42: R31         Supplemental Cash Flow Information (Tables)         HTML     52K 
43: R32         BUSINESS ACQUISITIONS Business Acquisitions Tables  HTML     93K 
                (Tables)                                                         
44: R33         Business Segment Information (Tables)               HTML     46K 
45: R34         Basis of Financial Statement Presentation           HTML     28K 
                (Details)                                                        
46: R35         Earnings Per Share (Reconciliation of Basic         HTML     50K 
                Earnings Per Share to Diluted Earnings Per Share)                
                (Details)                                                        
47: R36         Earnings Per Share (Potential common shares not     HTML     24K 
                included in computation of diluted earnings per                  
                share) (Details)                                                 
48: R37         Restructuring and Other Special Charges (Details)   HTML     91K 
49: R38         Restructuring Reserves (Details)                    HTML     53K 
50: R39         Goodwill and Intangible Assets (Changes in          HTML     65K 
                Carrying Amount of Goodwill) (Details)                           
51: R40         Goodwill and Intangible Assets (Components of       HTML     45K 
                identifiable intangible assets) (Details)                        
52: R41         Goodwill and Intangible Assets (Details)            HTML     55K 
53: R42         Debt (Senior Notes) (Details)                       HTML     93K 
54: R43         Debt (Convertible Subordinated Notes) (Details)     HTML     30K 
55: R44         Debt (Credit Facilities) (Details)                  HTML    113K 
56: R45         Preferred Stock and Common Shareholders' Equity     HTML     52K 
                (Details)                                                        
57: R46         Preferred Stock and Common Shareholders' Equity     HTML     84K 
                PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY -                
                Accumulated Other Comprehensive Earnings (Details)               
58: R47         Income Taxes (Details)                              HTML     27K 
59: R48         Commitments and Contingencies (Details)             HTML     67K 
60: R49         Pension and Postretirement Plans (Details)          HTML     95K 
61: R50         Pension and Postretirement Plans Defined            HTML     35K 
                Contribution Plans (Details)                                     
62: R51         Fair Value Measurements (Details)                   HTML     42K 
63: R52         Derivative Instruments and Hedging Activities       HTML     39K 
                (Details)                                                        
64: R53         Supplemental Cash Flow Information (Details)        HTML     40K 
65: R54         Business Acquisitions (Details)                     HTML    213K 
66: R55         Business Acquisitions Business Acquisitions in the  HTML    141K 
                Aggregate (Details)                                              
67: R56         BUSINESS SEGMENT INFORMATION Business Segment       HTML     58K 
                Information (Details)                                            
69: XML         IDEA XML File -- Filing Summary                      XML    121K 
68: EXCEL       IDEA Workbook of Financial Reports                  XLSX     82K 
 6: EX-101.INS  XBRL Instance -- lh-20160331                         XML   1.83M 
 8: EX-101.CAL  XBRL Calculations -- lh-20160331_cal                 XML    179K 
 9: EX-101.DEF  XBRL Definitions -- lh-20160331_def                  XML    909K 
10: EX-101.LAB  XBRL Labels -- lh-20160331_lab                       XML   1.67M 
11: EX-101.PRE  XBRL Presentations -- lh-20160331_pre                XML   1.17M 
 7: EX-101.SCH  XBRL Schema -- lh-20160331                           XSD    172K 
70: ZIP         XBRL Zipped Folder -- 0000920148-16-000193-xbrl      Zip    234K 


‘R9’   —   Earnings Per Share


This is an IDEA Financial Report.  [ Alternative Formats ]



 
v3.4.0.3
EARNINGS PER SHARE
3 Months Ended
Earnings Per Share [Abstract]  
Earnings Per Share
EARNINGS PER SHARE

Basic earnings per share is computed by dividing net earnings attributable to Laboratory Corporation of America Holdings by the weighted average number of common shares outstanding. Diluted earnings per share is computed by dividing net earnings including the impact of dilutive adjustments by the weighted average number of common shares outstanding plus potentially dilutive shares, as if they had been issued at the earlier of the date of issuance or the beginning of the period presented. Potentially dilutive common shares result primarily from the Company’s outstanding stock options, restricted stock awards, restricted stock units, performance share awards, and shares issuable upon conversion of zero-coupon subordinated notes.
The following represents a reconciliation of basic earnings per share to diluted earnings per share:
 
 
 Three Months Ended March 31,
 
 
2016
 
2015
 
 
Earnings
 
Shares
 
Per
Share
Amount
 
Earnings
 
Shares
 
Per
Share
Amount
Basic earnings per share:
 
 
 
 
 
 
 
 
 
 
 
 
Net earnings
 
$
160.2

 
101.6

 
$
1.58

 
$
3.1

 
91.9

 
$
0.04

Dilutive effect of employee stock options and awards
 

 
1.4

 
 

 

 
1.2

 
 

Effect of convertible debt
 

 
0.6

 
 

 

 
0.7

 
 

Diluted earnings per share:
 
 

 
 

 
 

 
 

 
 

 
 

Net earnings including impact of dilutive adjustments
 
$
160.2

 
103.6

 
$
1.55

 
$
3.1

 
93.8

 
$
0.04


The following table summarizes the potential common shares not included in the computation of diluted earnings per share because their impact would have been antidilutive:
 
 
Three Months Ended March 31,
 
 
2016
 
2015
Stock options
 
0.3

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:5/6/168-K
For Period end:3/31/16
 List all Filings 
Top
Filing Submission 0000920148-16-000193   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 16, 6:52:11.1pm ET